Bolt Biotherapeutics's total assets for Q1 2025 were $85.86M, a decrease of -13.82% from the previous quarter. BOLT total liabilities were $39.05M for the fiscal quarter, a -7.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.